Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 319 (RNA5SP319) is a genomic DNA segment classified as a **pseudogene** of the 5S ribosomal RNA (5S rRNA) gene family[4]. Pseudogenes are nonfunctional DNA sequences that resemble corresponding functional genes, but due to sequence changes or lack of key regulatory elements, do not encode functional RNA or protein products[4]. The canonical 5S rRNA is an essential small non-coding RNA that is a component of the ribosomal large subunit involved in protein synthesis[1][3][5]. However, pseudogene copies like RNA5SP319 are not transcribed into functional 5S rRNA, nor do they form part of the ribosome. While most pseudogenes are biologically inactive, a minority have been shown in other contexts to regulate gene expression or act as competing endogenous RNAs, sometimes impacting disease through RNA-based mechanisms in cancer[2][6]. There is currently no evidence that RNA5SP319 has any direct or unique biological function, disease role, or pharmacological relevance.
Not applicable (no drugs target this pseudogene; pseudogenes in general lack well-established mechanisms of therapeutic targeting)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 319 (RNA5SP319).